Last 12 months
Inside the activity.
1 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 6 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2018 Filed Jun 29, 2018 20:35 UTC |
Mariotti Brian RichardDirector · CHIEF EXECUTIVE OFFICER
|
GrantOption to Purchase Class A Common Stock · Derivative | 315,070 | $0.00 Strike: $11.71 | $0.00 |
DisclosureSEC source: 0000899243-18-018732 · doc4.xml · derivative · entry 2 Mariotti Brian Richard · CIK 0001719494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,070 Underlying: Class A Common Stock · 315,070 shares Expires 2028-06-27 F2 · derivative.exercise_date: The option will vest and become exercisable with respect to 25% of the shares subject thereto on June 27, 2019 and the remaining 75% of the option will vest in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:35 UTC |
Mariotti Brian RichardDirector · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 34,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-018732 · doc4.xml · derivative · entry 1 Mariotti Brian Richard · CIK 0001719494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,660 Underlying: Class A Common Stock · 34,660 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock or, at the election of the Issuer, an equivalent cash payment. The RSUs vest in four equal installments on each of the first through forth anniversaries of the date of grant, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock or, at the election of the Issuer, an equivalent cash payment. The RSUs vest in four equal installments on each of the first through forth anniversaries of the date of grant, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock or, at the election of the Issuer, an equivalent cash payment. The RSUs vest in four equal installments on each of the first through forth anniversaries of the date of grant, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. Read SEC document |
| November 06, 2017 Filed Nov 9, 2017 02:00 UTC |
IRVINE DIANE MDirector
|
GrantOption to Purchase Class A Common Stock · Derivative | 43,000 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0000899243-17-025694 · doc4.xml · derivative · entry 2 IRVINE DIANE M · CIK 0001287611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Class A Common Stock · 43,000 shares Expires 2027-10-31 F1 · date: The Option was granted effective November 1, 2017 (the "Pricing Date"), subject to the closing of the Issuer's initial public offering, which occurred on November 6, 2017. F2 · derivative.exercise_date: The Option will vest and become exercisable in eight (8) equal quarterly installments on the last business day of each calendar quarter following the Pricing Date, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. Read SEC document |
| November 06, 2017 Filed Nov 9, 2017 02:00 UTC |
IRVINE DIANE MDirector
|
PurchaseClass A Common Stock | 800 | $12.00 | $9,600.00 |
DisclosureSEC source: 0000899243-17-025694 · doc4.xml · nonDerivative · entry 1 IRVINE DIANE M · CIK 0001287611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Read SEC document |
| November 06, 2017 Filed Nov 9, 2017 00:58 UTC |
Perlmutter Andrew MarkPresident
|
GrantOption to Purchase Class A Common Stock · Derivative | 123,000 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0000899243-17-025650 · doc4.xml · derivative · entry 1 Perlmutter Andrew Mark · CIK 0001719492 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,000 Underlying: Class A Common Stock · 123,000 shares Expires 2027-10-31 F1 · date: The Option was granted effective November 1, 2017 (the "Pricing Date"), subject to the closing of the Issuer's initial public offering, which occurred on November 6, 2017. F2 · derivative.exercise_date: The Option was 25% vested as of the Pricing Date, and the remaining 75% of the shares subject to the Option will vest in three equal installments on each of the first three anniversaries of the Pricing Date, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. Read SEC document |
| November 06, 2017 Filed Nov 9, 2017 01:00 UTC |
DENSON CHARLES DDirector
|
PurchaseClass A Common Stock | 13,300 | $12.00 | $159,600.00 |
DisclosureSEC source: 0000899243-17-025653 · doc4.xml · nonDerivative · entry 1 DENSON CHARLES D · CIK 0001239159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,300 Read SEC document |
| November 06, 2017 Filed Nov 9, 2017 00:57 UTC |
Daw Tracy DSee Remarks
|
GrantOption to Purchase Class A Common Stock · Derivative | 103,000 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0000899243-17-025649 · doc4.xml · derivative · entry 2 Daw Tracy D · CIK 0001501098 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,000 Underlying: Class A Common Stock · 103,000 shares Expires 2027-10-31 F2 · date: The Option was granted effective November 1, 2017 (the "Pricing Date"), subject to the closing of the Issuer's initial public offering, which occurred on November 6, 2017. F3 · derivative.exercise_date: The Option will vest and become exercisable with respect to twenty-five percent (25%) of the shares subject thereto on the first anniversary of the Pricing Date, and the remaining 75% of the shares subject to the Option will vest in thirty-six (36) equal installments on each monthly anniversary following the first anniversary of the Pricing Date, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. Read SEC document |
| November 01, 2017 Filed Nov 9, 2017 00:57 UTC |
Daw Tracy DSee Remarks
|
Disposition to issuerCommon Stock | 100 | $0.00 | $0.01 |
DisclosureSEC source: 0000899243-17-025649 · doc4.xml · nonDerivative · entry 1 Daw Tracy D · CIK 0001501098 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · date: The reported securities represent shares of Common Stock of the Issuer, which were redeemed by the Issuer at a price equal to their par value in connection with the filing of its Amended and Restated Certificate of Incorporation on November 1, 2017. This transaction occurred prior to the registration of the Issuer's Class A Common Stock under Section 12 of the Securities Exchange Act of 1934, as amended. F1 · kind: The reported securities represent shares of Common Stock of the Issuer, which were redeemed by the Issuer at a price equal to their par value in connection with the filing of its Amended and Restated Certificate of Incorporation on November 1, 2017. This transaction occurred prior to the registration of the Issuer's Class A Common Stock under Section 12 of the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.